Background and objectives: Immunization against the coronavirus disease 2019 (COVID-19) began in January 2021 in Iran; nonetheless, due to a lack of vaccination among children under 12, this ... group is still at risk…
these genetics-analytical discoveries the whole of Mankind was salvation from Biological Lethal Weapons SARS-Cov2-19 and many mutational virions escaped intentionally or randomized from Biohazard boxes ... Human…
acute respiratory syndrome corona virus-2 (SARS-CoV-2), which is an enveloped RNA virus and highly contagious. This is a new coronavirus, still changing, and put the scientific authority ... fatality rate of COVID-19 is…
human life in both developing and developed countries. Basic precautionary measures for the novel Coronavirus SARS-CoV2 pandemic were created and practiced in coordination with these countries to slow infection ... used…
Abstract: The coronavirus SARS-COV-2 has turned our own health and the world economy upside down. While several vaccine candidates are currently under development, antivirals with the potential ... mass scale. The…
human coronavirus was discovered in 1960s, since then coronavirus family gained notoriety with the emergence of severe acute respiratory syndrome (SARS). In 2002/2003, SARS-CoV was identified that lasted ... which 803…
present pandemic of SARS-CoV-2 coronavirus disease 2019 (CVID-19) is particular challenge to Diabetes patients. May experience mild to more severe illnesses, organ failures, comorbidities and High risk ... Chronic…
patients differ care for emergency diseases. We analyze the impact of the SARS-CoV-2 coronavirus pandemic on the management of acute cholecystitis. Material and methods: Retrospective observational study that…
supplied worldwide in the present pandemic context. Targeting the nucleoprotein N of the SARS-CoV-2 coronavirus could be a strategy to impede viral replication and possibly other essential functions ... inflammatory…
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a multiple-organ infection. SARS-CoV-2 causes myocarditis, and by direct and non-direct pathological pathways may cause
disease 2019 (COVID-19). Therefore, reducing the viral load of Severe Acute Respiratory Syndrome- Coronavirus 2 (SARSCoV- 2) shed via respiratory droplets is potentially an ideal strategy to prevent ... virucidal…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.